Latest News

If you are wondering whether Bunge Global's share price fairly reflects its business today, you are not alone. This article is here to help you size up what you are actually paying for. The stock closed at US$113.94, with a 1.1% decline over the last 7 days, while returns sit at 20.8% over 30 days, 23.0% year to date, 70.2% over 1 year, 29.5% over 3 years and 71.1% over 5 years. These moves have put Bunge Global back on many investors radars, as they reassess what is already priced into the...

Why Eastman Chemical’s latest earnings and analyst reactions matter Eastman Chemical (EMN) has been in focus after its full year 2025 earnings and a cluster of analyst rating reaffirmations and price target changes, even as some international revenues and recent performance raised questions. See our latest analysis for Eastman Chemical. Despite weaker full year 2025 earnings, Eastman Chemical’s share price has shown strong recent momentum, with a 24.21% 3 month share price return and an...

Fidelity National Information Services, Inc. previously announced a 10% increase in its regular quarterly dividend to US$0.44 per common share, payable on March 24, 2026 to shareholders of record as of March 10, 2026, alongside ongoing cost-cutting and portfolio simplification efforts. Against the backdrop of a recent product launch in asset servicing and a higher dividend, the company’s renewed focus on core banking and capital markets technology is drawing fresh attention from investors...

First American Financial (NYSE:FAF) is experiencing a prolonged period of weak revenue and earnings per share growth. This extended phase of minimal topline and per share progress points to ongoing operational stagnation. The company’s growth trends continue to lag industry and broader market benchmarks. First American Financial, a major player in title insurance and related real estate services, sits at the crossroads of housing activity, mortgage volumes, and broader transaction trends...

If you are wondering whether Akamai Technologies is offering fair value right now, you are not alone. This article walks through what the current price might mean for long term investors. The share price closed at US$91.49 recently, with returns of 3.1% over the last 30 days, 7.5% year to date and a 1 year return of an 8.2% decline. This gives a mixed picture of how the market has been feeling about the stock. Recent news coverage around Akamai has focused on its role in content delivery,...

Brookfield Asset Management (TSX:BAM) is back in focus after appointing Connor Teskey as CEO, reporting fourth quarter 2025 results, and approving a 15% higher quarterly dividend of $0.5025 per share. See our latest analysis for Brookfield Asset Management. Those leadership changes, new deals in real estate and renewable projects, and the higher dividend come after a softer patch in trading, with a 30 day share price return of 12.5% and a 1 year total shareholder return decline of 16.9%...

Investors may be wondering if Marriott International at around US$326 per share still offers value, or if most of the opportunity has already been priced in. The stock has recorded returns of 2.1% over the last 7 days, 1.4% over 30 days, 4.2% year to date, 8.8% over 1 year, 92.4% over 3 years and 167.3% over 5 years. This raises fair questions about what you are paying for today. Recent attention on large branded hotel operators, including Marriott, has focused on how asset light models,...

It is hard to get excited after looking at Schaeffler India's (NSE:SCHAEFFLER) recent performance, when its stock has...

As the Australian market braces for a challenging day with a projected 1.2% drop, influenced by Wall Street's recent downturn, investors are keenly observing potential opportunities amidst the volatility. Penny stocks, often representing smaller or newer companies, might seem like a relic of past market trends but remain relevant today as they offer unique growth prospects at lower price points. By focusing on those with strong balance sheets and solid fundamentals, investors can uncover...

When close to half the companies in the Electrical industry in Korea have price-to-sales ratios (or "P/S") below 2.1x...

It's not a stretch to say that COSCO SHIPPING International (Hong Kong) Co., Ltd.'s ( HKG:517 ) price-to-earnings (or...

Most readers would already be aware that United Foods Company (PSC)'s (DFM:UFC) stock increased significantly by 11...

If you are wondering whether WEX at about US$148.54 is priced fairly or offering value, you are not alone. This article is built to help you size that up clearly. The stock has been choppy, with a 5.8% decline over the last 7 days and a 2.1% decline over the last 30 days, while year to date it is roughly flat at a 0.1% return and the 1 year return sits at a 2.2% decline, alongside 25.6% and 32.3% declines over 3 and 5 years respectively. These moves shape how investors think about risk and...

If you are wondering whether Thermon Group Holdings at about US$48.77 is still reasonably priced, or if the recent enthusiasm has already been factored in, this article walks through what the current valuation might be telling you. The stock has recently seen returns of 7.0% over the last 7 days, 26.8% over 30 days, 29.6% year to date and 83.9% over the past year, with multi year returns of 83.1% over 3 years and 200.3% over 5 years. These moves have come alongside ongoing interest in...

Kulicke and Soffa Industries (KLIC) kicked off Q1 2026 with total revenue of US$199.6 million and basic EPS of US$0.32, setting a cleaner earnings picture against a still loss making trailing twelve month profile. The company has seen quarterly revenue move from US$166.1 million in Q1 2025 to US$199.6 million in Q1 2026, while basic EPS shifted from US$1.52 in Q1 2025 through a volatile stretch that included losses in mid 2025 before landing at US$0.32 this quarter. This puts the focus firmly...

Ord Minnett recently downgraded Mineral Resources from Accumulate to Hold as the company updated lithium volume forecasts for its Wodgina and Mt Marion operations and reiterated that the planned partial sale of its lithium business to POSCO remains subject to approvals, with completion targeted in the first half of 2026. With firmer realised lithium prices underpinning higher production guidance and half-year results due on 20 February 2026, investors are reassessing how Mineral Resources’...

Verve Group (XTRA:M8G) has moved into focus after issuing 2026 earnings guidance, projecting revenue between €680 million and €730 million, alongside plans to present at Oppenheimer’s 11th Annual Emerging Growth Conference on 3 February 2026. See our latest analysis for Verve Group. The new 2026 guidance and upcoming conference appearance come after a sharp share price reset, with a 30 day share price return of 30.4% and a 1 year total shareholder return decline of 64.1%, suggesting sentiment...

Levi Strauss (NYSE:LEVI) has launched the Levi’s Wear Longer Project, a new program focused on clothing repair and sustainability education for Gen Z. The company is pairing the initiative with a Super Bowl week pop-up in San Francisco that features collaborations, live experiences, and community workshops on garment repair and creative reuse. For a brand built on denim and workwear, Levi Strauss is leaning into durability as part of its broader identity, rather than only selling new...

Progress Software, NasdaqGS:PRGS, is facing scrutiny after the recent ShareFile acquisition increased leverage and highlighted its dependence on deal driven growth. Industry commentary is focusing on the company’s organic growth trajectory and the risk of tougher year over year comparisons as ShareFile is fully reflected in results. Investors are weighing the impact of a more leveraged balance sheet and weaker underlying trends on the company’s future guidance and risk profile. Progress...

How Fox (FOXA) Has Been Performing Heading Into Q2 2026 Fox (FOXA) just posted Q2 2026 revenue of US$5.2b with basic EPS of US$0.53, putting fresh numbers on the board for investors watching its media earnings story. The company has seen quarterly revenue move from US$5.1b in Q2 2025 to US$5.2b this quarter, while EPS shifted from US$0.82 to US$0.53 over the same period. On a trailing twelve month basis, EPS sits at US$4.24 on revenue of US$16.6b. With net profit margin over the last year at...

Brookfield Asset Management appointed Connor Teskey as CEO, succeeding long time leader Bruce Flatt. Flatt remains as chair of Brookfield Asset Management and continues as CEO of parent company Brookfield Corp, TSX:BN. The leadership transition highlights an internal handover at one of the largest global alternative asset managers. Brookfield Asset Management sits at the center of global private capital, with large exposure to real assets such as infrastructure, real estate, and renewable...

Magnera (MAGN) just opened Q1 2026 with revenue of US$792 million and a basic EPS loss of US$0.96 per share, setting the tone for another quarter where top line and per share losses stay front and center for investors. Over the past year, the company has seen quarterly revenue move from US$702 million in Q1 2025 to US$792 million in Q1 2026, while basic EPS has ranged from a loss of US$1.69 in Q1 2025 to a loss of US$0.96 most recently, leaving margins under pressure and keeping the path to...

Mirum Pharmaceuticals agreed to acquire Bluejay Therapeutics, adding a late stage hepatitis D candidate to its rare liver disease pipeline. The deal expands Mirum's portfolio beyond its existing bile acid products, including those acquired from Travere Therapeutics. The company aims to widen its reach in rare liver diseases by reducing reliance on a single product and broadening treatment options for patients. Mirum Pharmaceuticals (NasdaqGM:MIRM), recently trading at about $98.23 per...

If you are wondering whether Bayer's share price still reflects its underlying worth after a strong run, you are not alone. The stock recently closed at €44.82, with returns of 1.8% over the last 7 days, 17.8% over 30 days, 17.9% year to date and 112.2% over the past year, set against 3 year and 5 year returns of 22.1% decline and 6.5% decline respectively. Recent news coverage has focused on Bayer's ongoing efforts to address its legacy issues and reposition its pharmaceutical and crop...